R&D

Bioclinica is utilizing data and technology to enable more efficient trial conduct. We are looking at ways to reduce the size of the trials, provide greater clarity into the effect of the drug, and to reduce the amount of complexity in the trial. We do this by improving trial design and utilizing advanced analytics to identify patients who would be high responders for a particular clinical trial.

Post : Drug Safety Scientist

CSMCRI with much scientific excitement has now achieved technological excellence with several granted patents in the core mandate of the institute and is one among the top performing national R&D laboratories in the country. At the beginning of 2011, the Institute has around 360 staff with 150 S&T staff on its roll and around 250 research fellows and project assistants pursing their doctoral programme.

Post : JRF/Project Associate-I: 1 No. in each project GAP 2117 and GAP 2118

During that time with the help and support of Dr. B.C. Roy an eminet physician and then chief minister of West Bengal, the foundation of the present day Chittaranjan Cancer Hospital(CCH) was laid.The hospital was formally inaugurated by Prof. Madam J.Curie in January 2,1950 and named after Deshbandhu Chittaranjan Das, as a tribute to and in the acknowledgment of the enormous donation of his land and property for the cause.Initially this was a Cancer treatment centre, which gradually expanded its activities in basic and clinical research with the assistance from goverment funding organzations.This eventually led to the founding of the Chittaranjan National Cancer Research Centre (CNCRC),funded by the Goverment of India in 1957, which was committed to basic research on cancer.

Post : Junior Research Fellow

Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country. The Company was a pioneer in initiating the concept of niche marketing in India and and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Expert Scientific Writer

AstraZeneca’s vision in Oncology is to help patients by redefining the cancer-treatment paradigm, with the aim of bringing six new cancer medicines to patients between 2013 and 2020. A broad pipeline of next-generation medicines is focused principally on four disease areas - breast, ovarian, lung and hematological cancers. As well as other tumor types, these are being targeted through four key platforms - immunotherapy, the genetic drivers of cancer and resistance, DNA damage repair, and antibody drug conjugates, underpinned by personalized healthcare and biomarker technologies.

Post : Patient Safety Scientist 1

All-India Institute of Medical Sciences was established as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in Undergraduate and Post-graduate Medical Education in all its branches so as to demonstrate a high standard of Medical Education in India; to bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity; and to attain self-sufficiency in Post-graduate Medical Education.

Post : Scientist-II

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Clinical Development Manager

Medreich is a fully integrated pharmaceutical company with an established presence across the globe. The company is involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories.  Medreich has an advanced state of the art Research and Development centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.

Post : R&D Scientist